Related Experiment Video
Updated: Jan 16, 2026

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.2K
Synthetic data for pharmacogenetics: enabling scalable and secure research.
Marko Miletic1, Anna Bollinger2, Samuel S Allemann2
1Institute for Optimisation and Data Analysis (IODA), Bern University of Applied Sciences, Biel, Switzerland.
JAMIA Open
|October 6, 2025
Summary
For pharmacogenetics research, traditional synthetic data generation methods like copula and synthpop provide a strong balance of data utility and privacy protection, outperforming deep learning models in many scenarios.
Area of Science:
- Pharmacogenetics
- Bioinformatics
- Data Science
Background:
- Synthetic data generation (SDG) is crucial for pharmacogenetics (PGx) research, especially with limited or sensitive patient data.
- Evaluating various SDG methods is essential to determine their suitability for complex PGx datasets.
- Assessing both data utility and privacy is critical for responsible data sharing and research.
Purpose of the Study:
- To evaluate the performance of seven synthetic data generation (SDG) methods for pharmacogenetics (PGx) research.
- To compare traditional and deep learning-based SDG approaches on high-dimensional genotype and phenotype PGx data.
- To assess SDG methods based on broad utility, specific utility, and privacy risk.
Main Methods:
- Seven SDG methods (synthpop, avatar, copula, copulagan, ctgan, tvae, tabula) were evaluated.
- PGx profiles from 142 patients were used, with scenarios including high-dimensional genotype (104 variables) and phenotype (24 variables) data.
- Performance was assessed using propensity score mean squared error (pMSE) for broad utility, weighted F1 score for specific utility, and ε-identifiability for privacy risk.
Main Results:
- Copula and synthpop demonstrated consistent strong performance, balancing low privacy risk (ε-identifiability: 0.25-0.35) with competitive utility.
- Deep learning models (tabula, tvae) achieved lower pMSE but had higher privacy risks (>0.4) and limited predictive gains.
- Specific utility (F1 score) was weakly correlated with broad utility (pMSE), indicating distributional fidelity does not guarantee predictive relevance.
Conclusions:
- No single SDG method excelled across all evaluation criteria.
- For privacy-sensitive PGx research, copula and synthpop offer a reliable trade-off between utility and privacy, particularly for high-dimensional, limited-sample datasets.
- Multimetric evaluation is essential, as general utility metrics do not always predict specific predictive utility.
Keywords:
artificial intelligence in healthcaredata privacygenomic datapharmacogeneticssynthetic dataMore Related Videos
Related Concept Videos
Analysis of Population Pharmacokinetic Data
677
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
677
Synthetic Biology
5.5K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
5.5K
Genetic Screens
5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K

